Revisiting the Use of sPLA2-Sensitive Liposomes in Cancer Therapy
It is still a pending issue for many “smart” nanocarriers endowed with a controlled and site-specific drug release mechanism to overcome the therapeutic efficacy and minimize therapy-associated side effects obtained by their older brothers, the golden
Category
Keywords
